| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-010405 |
| cik | 1896212 |
| name | CONDUIT PHARMACEUTICALS INC. |
| sic | 2834 |
| countryba | US |
| stprba | FL |
| cityba | NAPLES |
| zipba | 34103 |
| bas1 | 4851 TAMIAMI TRAIL NORTH |
| bas2 | SUITE 200 |
| baph | (646) 491 9132 |
| countryma | US |
| stprma | FL |
| cityma | NAPLES |
| zipma | 34103 |
| mas1 | 4851 TAMIAMI TRAIL NORTH |
| mas2 | SUITE 200 |
| countryinc | US |
| stprinc | DE |
| ein | 873272543 |
| former | MURPHY CANYON ACQUISITION CORP. |
| changed | 20211130 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-14 19:19:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010405 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010405 | 20241231 | Cash And Cash Equivalents At Carrying Value | 554000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1844000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -2384000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Derivative Liabilities Noncurrent | 138000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Fair Value Adjustment Of Warrants | -19000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250228 | Gains Losses On Extinguishment Of Debt | 100000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Convertible Promissory Note Payable; | ||
| 0001641172-25-010405 | 20240331 | General And Administrative Expense | 647000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Accounting And Audit Fees; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20250331 | General And Administrative Expense | 760000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Legal And Professional Fees; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20240331 | Increase Decrease In Accounts Payable | -97000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Interest Income Expense Nonoperating Net | -176000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Interest Income Expense Nonoperating Net | 24000000.0000 | USD | 1 | us-gaap/2024 | Short Term Debt Type= Convertible Promissory Notes Payable; | ||
| 0001641172-25-010405 | 20250331 | Net Income Loss | -5146000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Noncash Interest Expense | 167000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Noncash Lease Expense | 29000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20240331 | Nonoperating Income Expense | -597000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Nonoperating Income Expense | -1137000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Operating Expenses | 2955000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Operating Expenses | 4009000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Operating Income Loss | -2955000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Operating Income Loss | -4009000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Operating Income Loss | 4009000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20250331 | Operating Lease Right Of Use Asset | 234000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Other Nonoperating Income Expense | -969000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Other Notes Payable | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | |||
| 0001641172-25-010405 | 20240331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Repayment Of Notes Payable Related Parties | 425000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Repayments Of Notes Payable | 151000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Research And Development Expense | 128000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20231231 | Stockholders Equity | 10424000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20240331 | Stockholders Equity | -3099000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stockholders Equity | 2687000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stockholders Equity | 19000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 155257.0000 | shares | 0 | us-gaap/2024 | Title Of Individual= Non Employee Directors; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 4345866.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Issued For Services | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | 8167000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | 200000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= S A R B O R G Service Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010405 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 346000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Accounts Payable Current | 1428000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 414000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | 502000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20250331 | Amortization Of Debt Issuance Costs | 185000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 554000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Common Stock Shares Outstanding | 1384801.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Common Stock Value | 14000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Depreciation Expense | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20250331 | Fair Value Adjustment Of Warrants | -130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | General And Administrative Expense | 986000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Salaries Payroll And Stock Based Compensation; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20250331 | General And Administrative Expense | 693000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Salaries Payroll And Stock Based Compensation; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 255000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Interest Paid Net | 80000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Liabilities Assumed1 | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20240331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Net Cash Provided By Used In Financing Activities | 5927000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Net Cash Provided By Used In Operating Activities | -4329000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010405 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010405 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010405 | 20241231 | Other Notes Payable | 2871000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-010405 | 20241231 | Prepaid Expense And Other Assets Current | 1781000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Prepaid Rd Service | USD | 0 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20250331 | Prepaid Rd Services Related Party | 1814000.0000 | USD | 0 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20241231 | Property Plant And Equipment Net | 40000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Repayment Of Convertible Notes Payable | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20240331 | Repayment Of Notes Payable Related Parties | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20240331 | Repayments Of Notes Payable | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20241231 | Stockholders Equity | 14000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares Issued For Services | 2450191.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20230831 | Stock Issued During Period Shares New Issues | 65000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 1853933.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= S A R B O R G Additional Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | 12000000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= Sales Agreement; | ||
| 0001641172-25-010405 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Share Based Compensation | 234000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20250331 | Cash And Cash Equivalents At Carrying Value | 2130000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Convertible Notes Payable | 800000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Gains On Waiver Of Accrued Interest | -371000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20240331 | Increase Decrease In Operating Lease Liability | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | -207000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Investment Income Net | 9000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Liabilities | 10986000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Liabilities And Stockholders Equity | 4193000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Loss On Change In Fair Value Of Convertible Notes Payable | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010405 | 20250331 | Notes Payable Current | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | |||
| 0001641172-25-010405 | 20241231 | Operating Lease Liability Current | 119000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Operating Lease Liability Current | 126000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Operating Lease Liability Noncurrent | 100000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Lease Agreement; | ||
| 0001641172-25-010405 | 20250331 | Operating Lease Right Of Use Asset | 200000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Lease Agreement; | ||
| 0001641172-25-010405 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -23000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010405 | 20250331 | Other Notes Payable | 2663000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-010405 | 20250331 | Prepaid Expense And Other Assets Current | 1726000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Proceeds From Issuance Of Common Stock | 1500000.0000 | USD | 1 | us-gaap/2024 | Legal Entity= Astra Zeneca; | AstraZeneca | |
| 0001641172-25-010405 | 20240331 | Repayment Of Convertible Notes Payable Related Parties | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20240930 | Repayments Of Notes Payable | 60000.0000 | GBP | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20231231 | Stockholders Equity | 411000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010405 | 20241231 | Stockholders Equity | 21880000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20240331 | Stock Issued During Period Value Issuance Of Common Stock Upon Exercise Of Conversion Option | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | 100000.0000 | USD | 0 | us-gaap/2024 | Title Of Individual= Non Employee Directors; | ||
| 0001641172-25-010405 | 20250430 | Stock Issued During Period Value New Issues | 4200000.0000 | USD | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-010405 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 738295.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 3885758.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Operating Lease Liability Noncurrent | 107000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Additional Paid In Capital | 2400000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= April Lock Up Agreement; | ||
| 0001641172-25-010405 | 20250331 | Adjustment For Amortization | 100000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; Type Of Arrangement= S A R B O R G Service Agreement; | ||
| 0001641172-25-010405 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | 502000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010405 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 1576000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Common Stock Shares Issued | 9512058.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Common Stock Shares Outstanding | 9512058.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Common Stock Value | 19000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Earnings Per Share Basic | -4.8100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Earnings Per Share Diluted | -1.3200 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250131 | Gains Losses On Extinguishment Of Debt | 100000.0000 | USD | 0 | us-gaap/2024 | Legal Entity= Nirland Limited; | NirlandLimited | |
| 0001641172-25-010405 | 20250331 | Gains Losses On Extinguishment Of Debt | -1840000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Loss On Change In Fair Value Of Convertible Notes Payable | -274000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20240331 | Net Income Loss | -3552000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010405 | 20250331 | Notes Payable Current | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | |||
| 0001641172-25-010405 | 20250331 | Operating Lease Liability Current | 100000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= Lease Agreement; | ||
| 0001641172-25-010405 | 20250331 | Other Accrued Liabilities Current | 1045000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010405 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Repayment Of Convertible Notes Payable | 631000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Research And Development Expense | 1309000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Research And Development Expense | 1100000.0000 | USD | 1 | us-gaap/2024 | Related Party Transactions By Related Party= S A R B O R G Ltd; Type Of Arrangement= S A R B O R G Services Agreement; | ||
| 0001641172-25-010405 | 20241231 | Retained Earnings Accumulated Deficit | -29101000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20231231 | Stockholders Equity | -11299000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010405 | 20230930 | Stock Issued During Period Shares New Issues | 20000.0000 | shares | 0 | us-gaap/2024 | Business Acquisition= Murphy Canyon Acquisition Corp; Type Of Arrangement= Subscription Agreements; | ||
| 0001641172-25-010405 | 20240430 | Stock Issued During Period Shares New Issues | 9077.0000 | shares | 0 | us-gaap/2024 | Equity Components= Warrant; Title Of Individual= Director; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 175694.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 337079.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= Consulting Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 22727.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Type Of Arrangement= S A R B O R G Service Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Issued For Services | 2212000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250228 | Stock Issued During Period Value New Issues | 100000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Convertible Promissory Note; Equity Components= Common Stock; Type Of Arrangement= Consulting Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Share Based Compensation | 234000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 4080000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20250331 | Additional Paid In Capital | 500000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= March Lock Up Agreement; | ||
| 0001641172-25-010405 | 20240331 | Adjustment For Amortization | 422000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Adjustment Of Warrants Granted For Services | 502000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Adjustments To Additional Paid In Capital Warrant Issued | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -2357000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -27000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Liabilities Current | 4548000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Net Cash Provided By Used In Investing Activities | -4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010405 | 20250331 | Operating Lease Liability Noncurrent | 78000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -68000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010405 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Property Plant And Equipment Net | 41000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Stockholders Equity | 7000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20241231 | Stockholders Equity | -29101000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010405 | 20250331 | Stockholders Equity | 346000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010405 | 20240930 | Stock Issued During Period Shares New Issues | 11380.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 73074.0000 | shares | 0 | us-gaap/2024 | Debt Instrument= Convertible Promissory Note; Equity Components= Common Stock; Type Of Arrangement= Consulting Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Issued For Services | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010405 | 20240331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010405 | 20241231 | Additional Paid In Capital | 21880000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Additional Paid In Capital | 36569000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Amortization Of Debt Issuance Costs | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20250331 | Assets | 7321000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 4228000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 2130000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -18000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Foreign Currency Transaction Gain Loss Unrealized After Tax | -6000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Gains On Waiver Of Accrued Interest | USD | 1 | 0001641172-25-010405 | ||||
| 0001641172-25-010405 | 20240331 | General And Administrative Expense | 245000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Legal And Professional Fees; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20250331 | Increase Decrease In Operating Lease Liability | -28000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | 49000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Interest Income Expense Nonoperating Net | -119000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Investment Income Net | 8000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010405 | 20240331 | Operating Income Loss | 2955000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20241231 | Other Accrued Liabilities Current | 1963000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Research And Development Expense | 189000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Clinical Asset Development; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20231231 | Stockholders Equity | -457000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Stockholders Equity | 11357000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20250331 | Stockholders Equity | 36569000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20240930 | Stock Issued During Period Shares New Issues | 5690.0000 | shares | 0 | us-gaap/2024 | Investment Type= Loan Holders; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 1331200.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20241031 | Stock Issued During Period Value New Issues | 100000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Convertible Promissory Note; Equity Components= Common Stock; Type Of Arrangement= Consulting Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | 2000.0000 | USD | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-010405 | 20240331 | Stock Issued During Period Value Share Based Compensation | 431000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Stock Issued During Period Value Share Based Compensation | 431000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 738295.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 3885758.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Assets | 4193000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Assets Current | 2715000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 1594000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Comprehensive Income Net Of Tax | -3575000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Comprehensive Income Net Of Tax | -5214000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250228 | Convertible Notes Payable | 800000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Convertible Promissory Note Payable; Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Convertible Notes Payable | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Earnings Per Share Basic | -1.3200 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Earnings Per Share Diluted | -4.8100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Gains Losses On Extinguishment Of Debt | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Gains Losses On Extinguishment Of Debt | 100000.0000 | USD | 1 | us-gaap/2024 | Debt Instrument= Convertible Promissory Note Payable; | ||
| 0001641172-25-010405 | 20250331 | General And Administrative Expense | 544000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Accounting And Audit Fees; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20250331 | Liabilities | 4634000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Net Income Loss | -3552000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-010405 | 20250331 | Net Income Loss | -5146000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010405 | 20241231 | Notes Payable Current | 150000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-010405 | 20241231 | Notes Payable Current | 425000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-010405 | 20241231 | Operating Lease Right Of Use Asset | 263000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -68000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010405 | 20240331 | Other Nonoperating Income Expense | -487000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Other Notes Payable | 2985000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-010405 | 20241231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20241231 | Prepaid Expense And Other Assets Noncurrent | 1175000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Prepaid Expense And Other Assets Noncurrent | 1097000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Prepaid Rd Service | 279000.0000 | USD | 0 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Proceeds From Issuance Of Common Stock | 8061000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Repayment Of Convertible Notes Payable Related Parties | 927000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Retained Earnings Accumulated Deficit | -34247000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Share Based Compensation | 431000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20231231 | Shares Outstanding | 738295.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20240331 | Shares Outstanding | 738295.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Shares Outstanding | 9512058.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20231231 | Stockholders Equity | 7000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20240331 | Stockholders Equity | 388000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010405 | 20240331 | Stockholders Equity | -14851000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010405 | 20241231 | Stockholders Equity | 414000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-010405 | 20250331 | Stockholders Equity | -34247000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010405 | 20220731 | Stock Issued During Period Shares New Issues | 13000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Legal Entity= Alliance Global Partners; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares New Issues | 95044.0000 | shares | 1 | us-gaap/2024 | Legal Entity= Astra Zeneca; | AstraZeneca | |
| 0001641172-25-010405 | 20230930 | Stock Issued During Period Value New Issues | 20000000.0000 | USD | 0 | us-gaap/2024 | Type Of Arrangement= P I P E Subscription Agreement; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value New Issues | 8168000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 4077000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20250331 | Accounts Payable Current | 714000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Adjustment For Amortization | 369000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Adjustment Of Warrants Granted For Services | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Assets Current | 5949000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20241231 | Common Stock Shares Issued | 1384801.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Depreciation Expense | 5000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Derivative Liabilities Noncurrent | 8000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Foreign Currency Transaction Gain Loss Unrealized After Tax | 26000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | General And Administrative Expense | 2827000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | General And Administrative Expense | 2700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | General And Administrative Expense | 100000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Master Service Agreement; | ||
| 0001641172-25-010405 | 20250331 | Increase Decrease In Accounts Payable | -721000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 153000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Interest Paid Net | 170000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Liabilities And Stockholders Equity | 7321000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Liabilities Assumed1 | 350000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Liabilities Current | 10741000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Net Cash Provided By Used In Operating Activities | -2357000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010405 | 20240331 | Noncash Interest Expense | 79000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20240331 | Noncash Lease Expense | -25000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -68000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20240331 | Payments To Acquire Property Plant And Equipment | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010405 | 20250331 | Payments To Acquire Property Plant And Equipment | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Prepaid Rd Services Related Party | 380000.0000 | USD | 0 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20240331 | Research And Development Expense | 128000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Clinical Asset Development; Consolidation Items= Operating Segments; | ||
| 0001641172-25-010405 | 20250331 | Research And Development Expense | 1100000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= S A R B O R G Service Agreement; | ||
| 0001641172-25-010405 | 20250331 | Share Based Compensation | 234000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20241231 | Shares Outstanding | 1384801.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010405 | 20241231 | Stockholders Equity | -6793000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | shares | 1 | us-gaap/2024 | Award Type= Two Thousand Twenty Three Plan; | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Issuance Of Common Stock Upon Exercise Of Conversion Option | 4077000.0000 | USD | 1 | 0001641172-25-010405 | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Issued For Services | 2211000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Issued For Services | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010405 | 20250331 | Stock Issued During Period Value Share Based Compensation | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Warrant Issued | Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Interest Income Expense Nonoperating Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Stock Issued During Period Shares Issued For Services | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | |
| Gains On Waiver Of Accrued Interest | 0001641172-25-010405 | 1 | 0 | monetary | D | D | Gain on waiver of accrued interest | |
| Adjustment Of Warrants Granted For Services | us-gaap/2024 | 0 | 0 | monetary | D | D | Adjustment of Warrants Granted for Services | Adjustment for noncash service expenses paid for by granting of warrants. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Noncash Lease Expense | 0001641172-25-010405 | 1 | 0 | monetary | D | D | Operating lease obligations | Noncash lease expense. |
| Prepaid Rd Service | 0001641172-25-010405 | 1 | 0 | monetary | I | D | Prepaid R&D services (see Note 7) | |
| Repayment Of Convertible Notes Payable Related Parties | 0001641172-25-010405 | 1 | 0 | monetary | D | C | RepaymentOfConvertibleNotesPayableRelatedParties | Repayment of convertible notes payable - related parties. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Foreign Currency Transaction Gain Loss Unrealized After Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss), Foreign Currency Transaction, after Tax | Amount, after tax, of unrealized gain (loss) from foreign currency transaction. |
| Liabilities Assumed1 | us-gaap/2024 | 0 | 0 | monetary | D | C | Liabilities Assumed | The fair value of liabilities assumed in noncash investing or financing activities. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Depreciation Expense | 0001641172-25-010405 | 1 | 0 | monetary | D | D | Depreciation expense | Depreciation expense. |
| Noncash Interest Expense | 0001641172-25-010405 | 1 | 0 | monetary | D | D | Non-cash interest expense | Non-cash interest expense. |
| Derivative Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Derivative Liability, Noncurrent | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Prepaid Expense And Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Noncurrent | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed after one year or the normal operating cycle, if longer. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Value Issued For Services | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Loss On Change In Fair Value Of Convertible Notes Payable | 0001641172-25-010405 | 1 | 0 | monetary | D | D | Gain on debt extinguishment | Loss on change in fair value of convertible notes payable. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Repayments Of Notes Payable | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Notes Payable | The cash outflow for a borrowing supported by a written promise to pay an obligation. |
| Prepaid Rd Services Related Party | 0001641172-25-010405 | 1 | 0 | monetary | I | D | Prepaid R&D services- related party (see Note 7 and Note 12) | |
| Repayment Of Convertible Notes Payable | 0001641172-25-010405 | 1 | 0 | monetary | D | C | RepaymentOfConvertibleNotesPayable | Repayment of convertible notes payable. |
| Repayment Of Notes Payable Related Parties | 0001641172-25-010405 | 1 | 0 | monetary | D | C | RepaymentOfNotesPayableRelatedParties | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Amortization Of Debt Issuance Costs | 0001641172-25-010405 | 1 | 0 | monetary | D | D | Amortization Expense | Amortization of debt issuance costs. |
| Stock Issued During Period Value Issuance Of Common Stock Upon Exercise Of Conversion Option | 0001641172-25-010405 | 1 | 0 | monetary | D | C | Issuance of Common Stock Upon Exercise of Conversion Option | Stocki ssued during period value issuance of common stock upon exercise of conversion option |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Convertible Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Convertible Notes Payable | Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. |
| Gains Losses On Extinguishment Of Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Extinguishment of Debt | Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. |
| Fair Value Adjustment Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Investment Income Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Net | Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Adjustment For Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization | The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Other Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Notes Payable | Amount of long-term notes payable classified as other. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010405 | 6 | 12 | CF | 0 | H | Noncash Interest Expense | 0001641172-25-010405 | Non-cash interest expense | 0 |
| 0001641172-25-010405 | 2 | 9 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-010405 | 2 | 10 | BS | 0 | H | Prepaid Rd Services Related Party | 0001641172-25-010405 | Prepaid R&D services- related party (see Note 7 and Note 12) | 0 |
| 0001641172-25-010405 | 2 | 11 | BS | 0 | H | Prepaid Rd Service | 0001641172-25-010405 | Prepaid R&D services (see Note 7) | 0 |
| 0001641172-25-010405 | 2 | 12 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001641172-25-010405 | 2 | 13 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001641172-25-010405 | 2 | 14 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets. net | 0 |
| 0001641172-25-010405 | 2 | 15 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property, plant and equipment, net | 0 |
| 0001641172-25-010405 | 2 | 16 | BS | 0 | H | Prepaid Expense And Other Assets Noncurrent | us-gaap/2024 | Prepaid expenses and other long-term assets | 0 |
| 0001641172-25-010405 | 2 | 17 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001641172-25-010405 | 2 | 20 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-010405 | 2 | 21 | BS | 0 | H | Other Accrued Liabilities Current | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0001641172-25-010405 | 2 | 22 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability, current portion | 0 |
| 0001641172-25-010405 | 2 | 23 | BS | 0 | H | Convertible Notes Payable | us-gaap/2024 | Convertible promissory note payable | 0 |
| 0001641172-25-010405 | 2 | 24 | BS | 0 | H | Other Notes Payable | us-gaap/2024 | Convertible promissory notes payable at fair value | 0 |
| 0001641172-25-010405 | 2 | 25 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Notes payable | 0 |
| 0001641172-25-010405 | 2 | 26 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001641172-25-010405 | 2 | 27 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, non-current portion | 0 |
| 0001641172-25-010405 | 2 | 28 | BS | 0 | H | Derivative Liabilities Noncurrent | us-gaap/2024 | Derivative warrant liability | 0 |
| 0001641172-25-010405 | 2 | 29 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001641172-25-010405 | 2 | 30 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (see Note 15) | 0 |
| 0001641172-25-010405 | 2 | 32 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, par value $0.0001; 250,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively, 9,512,058 shares and 1,384,801 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001641172-25-010405 | 2 | 33 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, par value $0.0001; 1,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively; nil shares issued and outstanding at March 31, 2025 and December 31, 2024 | 0 |
| 0001641172-25-010405 | 2 | 34 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-010405 | 2 | 35 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-010405 | 2 | 36 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0001641172-25-010405 | 2 | 37 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity (deficit) | 0 |
| 0001641172-25-010405 | 2 | 38 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity (deficit) | 0 |
| 0001641172-25-010405 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-010405 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-010405 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-010405 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-010405 | 3 | 5 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001641172-25-010405 | 3 | 6 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001641172-25-010405 | 3 | 7 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001641172-25-010405 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001641172-25-010405 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development expenses | 0 |
| 0001641172-25-010405 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001641172-25-010405 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001641172-25-010405 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0001641172-25-010405 | 4 | 7 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income (expense), net | 0 |
| 0001641172-25-010405 | 4 | 8 | IS | 0 | H | Investment Income Net | us-gaap/2024 | Interest income | 0 |
| 0001641172-25-010405 | 4 | 9 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2024 | Interest expense | 0 |
| 0001641172-25-010405 | 4 | 10 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other (expense) income, net | 0 |
| 0001641172-25-010405 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010405 | 4 | 12 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per share | 0 |
| 0001641172-25-010405 | 4 | 13 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net loss per share | 0 |
| 0001641172-25-010405 | 4 | 14 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic weighted-average common shares outstanding | 0 |
| 0001641172-25-010405 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted weighted-average common shares outstanding | 0 |
| 0001641172-25-010405 | 4 | 17 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation adjustment | 0 |
| 0001641172-25-010405 | 4 | 18 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total comprehensive loss | 0 |
| 0001641172-25-010405 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010405 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010405 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Issued For Services | us-gaap/2024 | Issuance of common stock for services | 0 |
| 0001641172-25-010405 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Issued For Services | us-gaap/2024 | Issuance of Common Stock for services, shares | 0 |
| 0001641172-25-010405 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock under the ATM program | 0 |
| 0001641172-25-010405 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock under the ATM program, shares | 0 |
| 0001641172-25-010405 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Issuance of common stock upon exercise of conversion option | 0 |
| 0001641172-25-010405 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Issuance of common stock upon exercise of conversion option, shares | 0 |
| 0001641172-25-010405 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-010405 | 5 | 18 | EQ | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Foreign currency translation adjustment | 0 |
| 0001641172-25-010405 | 5 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010405 | 5 | 20 | EQ | 0 | H | Adjustments To Additional Paid In Capital Warrant Issued | us-gaap/2024 | Issuance of Warrants for lock-up | 0 |
| 0001641172-25-010405 | 5 | 21 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010405 | 5 | 22 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010405 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010405 | 6 | 4 | CF | 0 | H | Gains Losses On Extinguishment Of Debt | us-gaap/2024 | Loss on debt extinguishment, net | 1 |
| 0001641172-25-010405 | 6 | 5 | CF | 0 | H | Foreign Currency Transaction Gain Loss Unrealized After Tax | us-gaap/2024 | Unrealized foreign exchange loss (gain) | 1 |
| 0001641172-25-010405 | 6 | 6 | CF | 0 | H | Loss On Change In Fair Value Of Convertible Notes Payable | 0001641172-25-010405 | Gain on debt extinguishment | 0 |
| 0001641172-25-010405 | 6 | 7 | CF | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Gain on change in fair value of warrants | 0 |
| 0001641172-25-010405 | 6 | 8 | CF | 0 | H | Gains On Waiver Of Accrued Interest | 0001641172-25-010405 | Gain on waiver of accrued interest | 0 |
| 0001641172-25-010405 | 6 | 9 | CF | 0 | H | Noncash Lease Expense | 0001641172-25-010405 | Operating lease obligations | 0 |
| 0001641172-25-010405 | 6 | 10 | CF | 0 | H | Adjustment Of Warrants Granted For Services | us-gaap/2024 | Issuance of warrants for lock-up | 0 |
| 0001641172-25-010405 | 6 | 11 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0001641172-25-010405 | 6 | 13 | CF | 0 | H | Depreciation Expense | 0001641172-25-010405 | Depreciation expense | 0 |
| 0001641172-25-010405 | 6 | 14 | CF | 0 | H | Adjustment For Amortization | us-gaap/2024 | Amortization of financed Directors and Officers insurance | 0 |
| 0001641172-25-010405 | 6 | 15 | CF | 0 | H | Amortization Of Debt Issuance Costs | 0001641172-25-010405 | Amortization Expense | 0 |
| 0001641172-25-010405 | 6 | 17 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001641172-25-010405 | 6 | 18 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-010405 | 6 | 19 | CF | 0 | H | Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0001641172-25-010405 | 6 | 20 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Lease liability | 0 |
| 0001641172-25-010405 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash flows used in operating activities | 0 |
| 0001641172-25-010405 | 6 | 23 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases if property and equipment | 1 |
| 0001641172-25-010405 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash flows used in investing activities | 0 |
| 0001641172-25-010405 | 6 | 26 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common shares related to ATM program | 0 |
| 0001641172-25-010405 | 6 | 27 | CF | 0 | H | Repayment Of Notes Payable Related Parties | 0001641172-25-010405 | Repayment of notes payable related parties | 1 |
| 0001641172-25-010405 | 6 | 28 | CF | 0 | H | Repayments Of Notes Payable | us-gaap/2024 | Repayment of notes payable | 1 |
| 0001641172-25-010405 | 6 | 29 | CF | 0 | H | Repayment Of Convertible Notes Payable Related Parties | 0001641172-25-010405 | Repayment of convertible notes payable - related parties | 1 |
| 0001641172-25-010405 | 6 | 30 | CF | 0 | H | Repayment Of Convertible Notes Payable | 0001641172-25-010405 | Repayment of convertible notes payable | 1 |
| 0001641172-25-010405 | 6 | 31 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash flows provided by financing activities | 0 |
| 0001641172-25-010405 | 6 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net change in cash and cash equivalents before effect of exchange rate changes | 0 |
| 0001641172-25-010405 | 6 | 33 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of exchange rate changes on cash and cash equivalents | 0 |
| 0001641172-25-010405 | 6 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change in cash | 0 |
| 0001641172-25-010405 | 6 | 35 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0001641172-25-010405 | 6 | 36 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001641172-25-010405 | 6 | 38 | CF | 0 | H | Liabilities Assumed1 | us-gaap/2024 | Right of Use Asset obtained in exchange for Operating Lease Liabilities | 0 |
| 0001641172-25-010405 | 6 | 39 | CF | 0 | H | Stock Issued During Period Value Issuance Of Common Stock Upon Exercise Of Conversion Option | 0001641172-25-010405 | Issuance of Common Stock Upon Exercise of Conversion Option | 0 |
| 0001641172-25-010405 | 6 | 41 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |